Literature DB >> 3939585

Transient hyperphenylalaninaemia with a high neopterin to biopterin ratio in urine.

T Takahashi, S Kodama, H Nishio, T Takumi, T Matsuo, Y Hase, Y Sawada.   

Abstract

A case of transient hyperphenylalaninaemia with a maturational delay of dihydropteridine synthesis is described. With the Guthrie test, the patient showed a blood phenylalanine level of 38 mg dl-1, which had fallen to a normal value without a phenylalanine restricted diet by 3 months of age. The neopterin level and the neopterin to biopterin ratio in the patient's urine were very high at 19 days of age. The blood phenylalanine level did not decrease when tetrahydrobiopterin (2.5 mg kg-1) was administered at 19 days of age, while administration of tetrahydrobiopterin (7.5 mg kg-1) at 20 days of age had decreased the blood phenylalanine level to 50% of the preloading level after 24 h. The oral phenylalanine loading test showed the pattern of classic phenylketonuria (PKU) at 15 days of age, but it showed the normal pattern at 1 year 8 months of age.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3939585     DOI: 10.1007/bf01819290

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  11 in total

1.  Phenylketonuria due to a deficiency of dihydropteridine reductase.

Authors:  S Kaufman; N A Holtzman; S Milstien; L J Butler; A Krumholz
Journal:  N Engl J Med       Date:  1975-10-16       Impact factor: 91.245

2.  Developmental aspects of pteridine metabolism and relationships with phenylalanine metabolism.

Authors:  J L Dhondt; P Ardouin; J M Hayte; J P Farriaux
Journal:  Clin Chim Acta       Date:  1981-10-26       Impact factor: 3.786

3.  Neopterin and biopterin levels in patients with atypical forms of phenylketonuria.

Authors:  J C Nixon; C L Lee; S Milstien; S Kaufman; K Bartholomé
Journal:  J Neurochem       Date:  1980-10       Impact factor: 5.372

4.  Dihydropteridine reductase deficiency: diagnosis by leukocyte enzyme assay.

Authors:  K Narisawa; N Arai; S Ishizawa; Y Ogasawara; A Onuma; K Iinuma; K Tada
Journal:  Clin Chim Acta       Date:  1980-08-19       Impact factor: 3.786

Review 5.  Tetrahydrobiopterin deficiencies: preliminary analysis from an international survey.

Authors:  J L Dhondt
Journal:  J Pediatr       Date:  1984-04       Impact factor: 4.406

6.  Atypical phenylketonuria with defective biopterin metabolism. Monotherapy with tetrahydrobiopterin or sepiapterin, screening and study of biosynthesis in man.

Authors:  A Niederwieser; H C Curtius; M Wang; D Leupold
Journal:  Eur J Pediatr       Date:  1982-03       Impact factor: 3.183

7.  Excretion of pterins in phenylketonuria and phenylketonuria variants.

Authors:  A Niederwieser; H C Curtius; R Gitzelmann; A Otten; K Baerlocher; B Blehovà; S Berlow; H Gröbe; F Rey; J Schaub; S Scheibenreiter; H Schmidt; M Viscontini
Journal:  Helv Paediatr Acta       Date:  1980-09

8.  Biopterin defect in a normal-appearing child affected by a transient phenylketonuria.

Authors:  F Rey; R J Leeming; J A Blair; J Rey
Journal:  Arch Dis Child       Date:  1980-08       Impact factor: 3.791

9.  Atypical phenylketonuria caused by 7, 8-dihydrobiopterin synthetase deficiency.

Authors:  A Niederwieser; H C Curtius; O Bettoni; J Bieri; B Schircks; M Viscontini; J Schaub
Journal:  Lancet       Date:  1979-01-20       Impact factor: 79.321

10.  Diagnosis of variants of hyperphenylalaninemia by determination of pterins in urine.

Authors:  J L Dhondt; C Largilliere; P Ardouin; J P Farriaux; M Dautrevaux
Journal:  Clin Chim Acta       Date:  1981-03-05       Impact factor: 3.786

View more
  2 in total

1.  Neonatal hyperphenylalaninaemia presumably caused by a new variant of biopterin synthetase deficiency.

Authors:  J L Dhondt; P Guibaud; M O Rolland; C Dorche; S Andre; G Forzy; J M Hayte
Journal:  Eur J Pediatr       Date:  1988-02       Impact factor: 3.183

Review 2.  Atypical cases of phenylketonuria.

Authors:  J L Dhondt; J P Farriaux
Journal:  Eur J Pediatr       Date:  1987       Impact factor: 3.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.